# Enzymit

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enzymit

- Industry: Biotechnology
- Headquarters: Ness Ziona, Israel
- Website: www.enzymit.com
- Total disclosed funding: $15M
- Latest round: Series A (Sep 25, 2024)
- Investors on record: 5

## About

Based in Ness Ziona, Israel, and founded by Dror Baran (COO) and Gideon Lapidoth (CEO, CTO) in 2020, Enzymit Ltd., is a platform that uses computational design tools to create novel bio enzymes and biomolecular components in a cost-effective manner. In April 2022, Enzymit Ltd. raised USD 5 million in seed funding led by new investor First Star Ventures, with participation from other new investors NextLeap Ventures and Sapir Venture Partners. 

The firm uses data gathered from protein sequence changes and applies deep learning algorithms to create a new chemistry enzyme design pipeline. The company develops enzymes that meet human needs, catalyze new reactions, and exceed existing enzymes without the use of toxic cell-manufacturing processes. Enzymit develops novel enzymatic processes that convert carbon from the atmosphere into new biopolymers that do not occur naturally in Nature at a lower cost and in a more environmentally friendly manner.

The company intends to use the April 2022 funds to accelerate the development of its computational design platform and expand its product pipeline.

## Funding rounds

- Series A, Sep 25, 2024, $10M — Khosla Ventures, First Star Ventures, Grove, Sapir Venture Partners
- Seed, Apr 6, 2022, $5M — First Star Ventures, NextLeap Ventures, Sapir Venture Partners

## Investors

- First Star Ventures (https://capitalatlas.ai/funds/first-star-ventures) — Seed, Series A
- NextLeap Ventures (https://capitalatlas.ai/funds/nextleap-ventures) — Seed
- Sapir Venture Partners (https://capitalatlas.ai/funds/sapir-venture-partners) — Seed, Series A
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A
- Grove (https://capitalatlas.ai/funds/grove) — Series A